These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8544926)

  • 21. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action, clinical indication and results of treatment of botulinum toxin].
    Lagueny A; Burbaud P
    Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
    Wang J; Zhang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical guidelines: No more mistaken identities for botulinum neurotoxins.
    Albanese A
    Nat Rev Neurol; 2016 Jul; 12(7):373-4. PubMed ID: 27313106
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of facial spasm with botulin A toxin].
    Adenis JP; Smolik I; Maes S
    J Fr Ophtalmol; 1990; 13(5):259-64. PubMed ID: 2258549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blepharospasm treatment with botulinum toxin (follow-up)].
    Roggenkämper P
    Klin Monbl Augenheilkd; 1986 Oct; 189(4):283-5. PubMed ID: 3807220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of blepharospasm and hemifacial spasm with botulinum A toxin].
    Dai Z
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):144-5. PubMed ID: 8223038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical application of botulinum toxin].
    Mezaki T
    Brain Nerve; 2011 Jul; 63(7):785-94. PubMed ID: 21747149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening.
    Defazio G; Lepore V; Lamberti P; Livrea P; Ferrari E
    Ital J Neurol Sci; 1990 Jun; 11(3):275-80. PubMed ID: 2387698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-reported benefit and weakness after botulinum toxin in dystonia.
    Kassavetis P; Lungu C; Ehrlich D; Alter K; Karp BI
    Parkinsonism Relat Disord; 2020 Nov; 80():10-11. PubMed ID: 32927341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.